ICAM1 and cancer: This aggressive phenotype of circulating cancer cells is not only conferred by facilitating TEM from the endothelial side but also by enabling collective migration of cell aggregates between ICAM-1 on cancer cells and β2 integrins on leukocytes, which can promote the proliferation of secondary tumours trapped in post-capillary venules [93].